Vardeny, O., Fang, J. C., Desai, A. S., Jhund, P. S., Claggett, B., Vaduganathan, M., … Solomon, S. D. (2023). Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med, 29(12), 3269. https://doi.org/10.1038/s41591-023-02302-x

Vardeny, Orly, James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A. de Boer, et al. “Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.” Nat Med 29, no. 12 (December 2023): 3269. https://doi.org/10.1038/s41591-023-02302-x.

Vardeny O, Fang JC, Desai AS, Jhund PS, Claggett B, Vaduganathan M, et al. Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med. 2023 Dec;29(12):3269.

Vardeny, Orly, et al. “Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.” Nat Med, vol. 29, no. 12, Dec. 2023, p. 3269. Pubmed, doi:10.1038/s41591-023-02302-x.

Vardeny O, Fang JC, Desai AS, Jhund PS, Claggett B, Vaduganathan M, de Boer RA, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, Kosiborod MN, DeMets D, O’Meara E, Zieroth S, Comin-Colet J, Drozdz J, Chiang C-E, Kitakaze M, Petersson M, Lindholm D, Langkilde AM, McMurray JJV, Solomon SD. Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nat Med. 2023 Dec;29(12):3269.